-
-
Call more information
660-596-2224 -
Author: Helen Olkaba, MS ASA Monitor April 2024, Vol. 88, 30. G2211 – Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient’s single, serious condition […]
Read MoreASA Monitor April 2024, Vol. 88, 14. AI digital biomarker for lung fibrosis diagnosis Imvaria Inc. has gained FDA approval for Fibresolve, an AI-driven digital biomarker solution facilitating noninvasive diagnosis of lung fibrosis, notably idiopathic pulmonary fibrosis (IPF). Lung fibrosis is a life-threatening disease, with IPF being particularly devastating. Current therapies are expensive and potentially toxic […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review ASCs are facing major obstacles to securing anesthesia coverage, and the decline in reimbursements is exacerbating the issue. Here are six notes about the decline of reimbursements: 1. The average anesthesia reimbursement rate for 2023 was $21.88, a 5.5% decline from 2019, according to a Jan. 16 blog post from Coronis […]
Read MoreAuthor: Jennifer R. Root, MD, FASA ASA Monitor April 2024, Vol. 88, 32. For most of my career, when I have seen something unusual (like a sneeze under a general anesthetic – I’ve seen it twice now), the only people to discuss it with are your partners. And unless you are in an academic environment, that […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Raynaldo Ortiz Jr., MD, an anesthesiologist who allegedly injected heart-stopping drugs into IV bags at Baylor Scott & White Surgicare North Dallas, appeared in court ahead of his trial, which is set to begin April 1, according to ABC affiliate WFAA. Dr. Ortiz has been in federal custody since his […]
Read MoreASA Monitor April 2024, Vol. 88, 14. “GO chip” for monitoring cancer treatment A study from the University of Michigan introduces a chip for processing blood samples to monitor cancer cells, providing an early assessment of efficacy by the fourth week of treatment. The technology aims to reduce the delay in evaluating cancer treatments, enabling timely […]
Read MoreAUTHORS: Gurunathan, Usha FANZCA et al Anesthesia & Analgesia 138(4):p 763-774, April 2024. BACKGROUND: There is limited evidence to inform the association between the intake of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) and intraoperative blood pressure (BP) changes in an ambulatory surgery population. METHODS: Adult patients who underwent ambulatory surgery and were discharged on […]
Read MoreAuthor: Kelly Wolfgang ASA Monitor April 2024, Vol. 88, 27. Emerging evidence suggests that patients who suffer hip fractures and other traumatic injuries are at risk of prolonged opioid use when inadequate analgesia occurs. For anesthesiologists, proper acute pain management is imperative, from preoperative patient assessment to the postoperative recovery stage. Uncontrolled pain can be detrimental, […]
Read MoreAuthor: Patsy Newitt Becker’s Physician Leadership The anesthesia provider shortage is a continuing obstacle in care provision, as reimbursements decline, and physicians leave the workforce. Here are five key numbers on the anesthesia provider shortage to know: 1. Nearly 30% of anesthesiologists are predicted to leave the practice by 2033, according to a 2023 white paper from Medicus Healthcare […]
Read MoreAuthors: Andrew King, MD, MS et al ASA Monitor April 2024, Vol. 88, 33. A family history of deaths under general anesthesia – an unlikely nightmare for the modern anesthesiologist. But for Dr. Jim Villiers, that was a challenge he had to face for his patient in 1960s Melbourne, Australia. Malignant hyperthermia (MH), a topic […]
Read More